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Abstract
Background: An increase in serum uric acid (UA) occurs during the early and middle stages of chronic kidney
disease (CKD) and aggravates the deterioration of kidney function. This study aims to explore the relation between
UA and endothelial dysfunction in early CKD and its mechanisms in a murine model.
Methods: The experimental animals were randomly divided into three groups (n = 10): sham-operation group
(control group), right nephrectomy only group (CKD group) and right nephrectomy with oxonic potassium group
(CKD with hyperuricemia group). Furthermore, we analyzed the relation between UA and endothelial dysfunction
indices in early CKD as well as its mechanisms.
Results: Linear regression analysis showed that the level of serum UA had a significant positive correlation with
serum endothelin-1 and the percentage of collagen I positive area, but a negative correlation with serum nitric
oxide (NO) and NO/endothelin-1 ratio. In addition, the level of serum UA had significant positive correlations with
serum malonaldehyde, serum C-reactive protein, serum oxidatively-modified low-density lipoprotein and serum
low-density lipoprotein, but a negative correlation with serum superoxide dismutase.
Conclusions: Endothelial dysfunction in the CKD group was significant and had a positive correlation with the level
of serum UA. Endothelial dysfunction in early CKD with hyperuricemia is perhaps related to oxidative stress,
micro-inflammation and lipid oxidation.
Keywords: Early chronic kidney disease, Endothelial dysfunction, Lipid oxidation, Micro-inflammation, Oxidative
stress, Uric acid
Background
Since previous studies have highlighted the role of serum
uric acid (UA) in coronary heart disease [1], the effect
and mechanism of UA in cardiovascular disease (CVD)
has aroused widespread concern. Serum UA level is not
only the most significant predictor of occurrence of pri-
mary hypertension [2], but it is also associated with car-
diovascular morbidity and mortality [3-5].
Chronic kidney disease (CKD) affects 10–13% of the
general population. CKD patients have an extremely
high risk of developing CVD compared with the general
population. Patients in the early stages of CKD are more
likely to convert into CVD rather than progress towards
end-stage renal disease [6]; CVD is the major cause of
death in patients with CKD [7]. The increase in serum
UA occurs in the early and middle stages of CKD
and aggravates with the deterioration of kidney func-
tion [8]. At present, no publication has demonstrated
the effect and mechanism of UA in early CKD with
CVD patients. Our earlier clinical study found that
serum UA was increased in patients with stage 2–3
CKD and was related to CVD (e.g. left ventricular
hypertrophy), indicating that hyperuricemia was asso-
ciated with CVD in early CKD.
Endothelial dysfunction is an early occurrence in
CVD. Vascular endothelial cells play an important role
in cellular functions, such as modulating angiokinesis,
the proliferation and migration of vascular smooth
muscle cells, anti-platelet aggregation, and extracellular
matrix generation. Pathological changes in blood ves-
sels, including intima hyperplasia, lumen straightness
and atherosclerosis, are a consequence of endothelial
dysfunction. In the clinic, endothelial dysfunction is
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associated with CVD, and specifically with hyperten-
sion, coronary heart disease, thrombosis, and cardiac
insufficiency [9-11]. Endothelial cells can synthesize
and excrete many important substances, the serum
levels of which will change in the condition of endothe-
lial dysfunction, such as decreased nitric oxide (NO)
level, increased endothelin-1 (ET-1) level, and de-
creased NO/ET-1 ratio [12,13]. Thus, the content of
NO and ET-1 is important for evaluating the function
of endothelial cells. Collagen I deposition in the ar-
tery is also related to the function of endothelial cells;
endothelial cell dysfunction increases the excretion of
transforming growth factor-β (TGF-β) and other sub-
stances of collagenous protein synthesis, leading to
the deposition of abundant collagen I in the artery.
Endothelial cell injury is generally related to genetic
factors, lifestyle, age, obesity, smoking, blood pressure
(pulse pressure), heart dysfunction, fasting hyperglycemia
(impaired glucose tolerance) and insulin resistance. The
unique status of CKD, namely oxidative stress, micro-
inflammation, and lipid oxidation [14], can also cause
endothelial cell injury. At present, studies exploring the
mechanisms of endothelial cell injury in CKD patients
mainly focus on end-stage renal disease patients. The
mechanism of UA-induced endothelial damage in early
CKD is not well known.
Despite recent advances in the treatment of CKD, the
disease remains an important public health challenge
[15]. Traditional risk factors, such as hypertension and
hypercholesterolemia, cannot explain the excess cardio-
vascular mortality in CKD patients. Identifying and
treating risk factors of early CKD may be the best ap-
proach to prevent and delay adverse outcomes [16].
Through the establishment of early CKD animal models
with elevated serum UA, we explored the relationship
between UA and vascular endothelial cell damage, and
further investigated the mechanisms of injury in order to
elucidate intervening CVD risk factors as early as pos-
sible in CKD patients.
Methods
Reagents and antibodies
NO, superoxide dismutase (SOD), and malondialdehyde
(MDA) detection kits were purchased from Nanjing
KeyGEN Biotech. Co. Ltd. (Nanjing, China). Oxidatively
modified low-density lipoprotein (ox-LDL), ET-1, and C-
reactive protein (CRP) detection kits were purchased
from ADL (Adlitteram Diagnostic Laboratories, USA).
Diaminobenzidine chromogenic kit, rabbit anti-mouse
collagen I polyclonal antibody, and goat anti-rabbit poly-
clonal antibody were purchased from Fuzhou Maixin
Biotechnology Co. Ltd. (Fujian, China). Beckman CX9
biochemical analyzer and Beckman supporting reagents
were purchased from Beckman Coulter (USA).
The establishment of early CKD animal model with
hyperuricemia
Thirty male Sprague-Dawley rats, weighing 187 g to
232 g and 6 to 7 weeks old, obtained from Xipuer-bikai
experimental animal company (Shanghai, China), were
employed in the present study. All experimental proce-
dures were conducted in accordance with the Guiding
Principles for the Care and Use of Animals in Research
and Teaching, approved by the Institutional Animal
Care and Use Committee of Jinshan Hospital affiliated
to Fudan University, China.
The experimental animals were randomly divided into
three groups (n = 10): sham-operation group (control
group, Group A), right nephrectomy-only group (CKD
group, Group B), and right nephrectomy with oxonic po-
tassium group (CKD with hyperuricemia group, Group
C). The rats were housed in standard plastic cages; food
and water were freely available.
The experimental animals were anesthetized using an
intraperitoneal injection at a dose of 5% ketamine
(100 mg/kg). The surgical region was shaved and the
shin was cleaned with 75% alcohol. The right kidney
was exposed through a longitudinal incision under
the right costal arch (proximal to the right side of
the spine). For Groups B and C, the right kidney was
resected. The entire procedure was performed in the
sham group, but nephrectomy was not applied. After
one week of normal feeding, the rats in all three
groups were in good condition. The experimental
group was fed with uricase inhibitor (oxonic potas-
sium) twice a day (800 mg/kg, at 8 a.m. and 5 p.m.)
by gavage. During the experiment, rats were weighed
every two weeks and the administered dose was ad-
justed based on body weight. Unilateral nephrectomy
group and the sham-operation group were fed with
the same amount of saline.
Sample collection and management
After ten weeks of gavage administration, rats were
killed and blood samples were collected from the heart
into non-heparinized tubes. The blood sera were then
collected via centrifugation and stored at −70°C for de-
tection of UA, serum creatinine (Scr), NO, ET-1, CRP,
MDA, SOD, ox-LDL, and LDL. For light microscopic
examination, left kidney tissues from each group were
fixed with 10% formalin, stored at 4°C for 14 to 16 hours,
and then embedded with paraffin. After routine process-
ing, paraffin sections of each tissue were cut into 4-μm
thickness and stained with periodic acid-Schiff. The
aorta tissue from descending aorta was cut, washed with
0.9% saline, and embedded in paraffin. After routine pro-
cessing, paraffin sections of each tissue were cut into 4-
μm thickness for hematoxylin-eosin (HE) staining and
determination of collagen I.
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The detection of serologic indexes
The detection of Scr, UA, serum NO, serum ET-1,
serum SOD, serum MDA, serum CRP, serum LDL, and
ox-LDL was performed according to the instructions in
the kits.
Statistical analysis
The proportion of collagen I positive area was measured
by randomly selecting three fields in each slide and div-
iding each field into 1,564 parts by Photoshop. The
number of positive points were counted; the proportion
was the number of positive points/1,564. Data were cal-
culated by two examiners and the average values were
calculated.
All data were expressed by x̄ ± s. Statistical analysis
was performed using the Statistical Package for Social
Sciences (SPSS for windows, version 13.5). Comparisons
between groups were analyzed using the t-test. Variable
comparisons were assessed using one-way analysis of
variance (ANOVA) and multiple stepwise regression
analysis. A P value < 0.05 was considered as significant.
Results
Early CKD animal model with hyperuricemia
Group A (sham operation) and group B (right nephrec-
tomy only) served as controls. Group C (right nephrectomy
with oxonate potassium) was the experimental group.
Periodic acid-Schiff staining of kidney tissues from
each group showed mild glomerular mesangial prolifera-
tion in groups B and C, compared to group A (Figure 1A,
C,E). No obvious pathological change in renal tubule and
renal interstitium was visible in the three groups. Mean-
while, there was no renal tubular epithelial cells necrosis,
no inflammatory cells in the interstitium, and no small
vessel lesions in groups B and C (Figure 1D,F). In the ex-
perimental group, there was no urate crystal deposition.
Compared with groups A and B, the experimental group
had a significantly higher level of UA. However, there was
no obvious difference in Scr among the three groups
(Table 1), which was in accordance with the characteristics
of early CKD. The above results indicate the establishment
of an early CKD animal model with hyperuricemia.
Vascular endothelial cell injury in the experimental group
In the light microscope, endothelial cells of group A
were arranged closely under the vascular intima and in-
flammatory cells did not accumulate in the vascular wall
(Figure 2A); smooth muscle cells were arranged in order
with a spindle shape and an almost uniform morphology
(Figure 2B). However, in group C, a foam-like interstitial
edema of endothelial cells was visible (Figure 2E). Partial
endothelial cells was shed from the vessel wall and the
gap between them was broadened (Figure 2F). Further,
inflammatory cells accumulated in the vascular intima
(Figure 2G,H) and several inflammatory cells infiltrated
within the membrane (Figure 2I,J). The thickness of the
blood vessel wall increased. Medial smooth muscle cells
proliferated and thickened with an irregular shape and a
disordered arrangement (Figure 2K). The pathological
change of the right-side nephrectomy group (group B)
was similar to the experimental group, but less marked
(Figure 2C). Smooth muscle cell proliferation was not
obvious and it was well arranged (Figure 2D). The re-
sults confirmed significant vascular injury in the experi-
mental group.
Collagen I staining of the vascular wall in the three
groups is shown in Figure 3. Several collagen I deposi-
tions were visible in the vascular wall of groups A and B,
while the collagen I component was significantly in-
creased in group C. Statistical analysis showed that
the percentage of collagen I positive area in the vessel
wall of the experimental group was significantly higher
than that of group A and group B (group C vs. group
A, P < 0.01; group C vs. group B, P < 0.01) (Table 1).
Blood NO and ET-1 were important values to reflect
the function of endothelial cells. Compared to groups A
and B, in the experimental group, serum NO level was
low (P < 0.01), serum ET-1 level was high (P < 0.05), and
the NO/ET-1 ratio was low (P < 0.01). The above results
verified endothelial cell dysfunction and significant in-
jury of vascular endothelial cells.
Uric acid-induced vascular endothelial cell injury in
early CKD
The possibility of a direct correlation between elevated
UA level and vascular disease as well as endothelial in-
jury was also investigated. Linear regression analysis
showed that the level of serum UA had a significant
positive correlation with the percentage of collagen I posi-
tive area (r = 0.8403, P < 0.01) and serum ET-1 (r = 0.9374,
P < 0.01), but a negative correlation with serum NO
(r = −0.9462, P < 0.01) and NO/ET-1 ratio (r = −0.9230,
P < 0.01) (Table 2). The percentage of collagen I positive
area had a significant positive correlation with serum
ET-1 (r = 0.8737, P < 0.01), but a negative correlation
with serum NO (r = −0.9171, P < 0.01) and NO/ET-1
ratio (r = −0.8707, P < 0.01) (Table 3). The results indi-
cated that UA induced vascular endothelial cell injury in
early CKD and the production of collagen I in the vascular
wall. Meanwhile, the production of collagen I was relative
to the injury of endothelial cells.
Uric acid caused vascular endothelial injury in early CKD
by oxidative stress, micro-inflammation, and lipid
oxidation mechanisms
The above experiments showed that UA was involved in
early CKD vascular endothelial cell injury; however, the
mechanism is unclear. Basic research demonstrated that
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UA crystals deposited in the intima could directly cause
endothelial cell damage. Whether there are other im-
portant mechanisms apart from this remains to be
investigated.
Our research showed that the experimental group had
lower level of serum SOD (U/mL) compared with groups
A and B (group C vs. group A, P < 0.01; group C vs. group
B, P < 0.01) and higher level of serum MDA (nmol/mL)
(group C vs. group A, P < 0.01; group C vs. group B,
P < 0.05) (Table 4). Linear regression analysis showed
that the level of serum UA had a significant positive
correlation with serum MDA (r = 0.8195, P < 0.01), but a
negative correlation with serum SOD (r = −0.6885, P <
0.05), which indicated that UA might lead to oxidative
stress in early CKD. Further, the level of serum NO
had a significant positive correlation with serum SOD
(r = 0.8179, P < 0.01), but a negative correlation with
serum MDA (r = −0.9171, P < 0.01). The level of
Table 1 Concentration of Src, UA, PCIPA, NO, ET-1 and NO/ET-1 ratio in three groups (x±̅s)
Group Scr (μmol/L) UA (μmol/L) PCIPA (%) NO (μmol/L) ET-1 (pg/mL) NO/ET-1
A 30.20 ± 6.01 53.10 ± 8.62 12.90 ± 2.31 47.55 ± 5.39 5.89 ± 1.67 8.18 ± 2.32
B 31.70 ± 4.72 53.70 ± 11.52 12.97 ± 2.71 45.34 ± 4.76 5.92 ± 1.56 8.90 ± 3.55
C 30.80 ± 5.90 161.40 ± 28.04* 22.38 ± 3.14* 36.71 ± 3.45* 7.50 ± 1.06△ 5.07 ± 1.19*
Note:
*: P <0.01 group C vs. groups A and B.
△: P <0.05 group C vs. groups A and B.
PCIPA: Percentage of collagen I positive area.
Figure 1 Pathological pictures of rat kidneys from groups A, B, and C. (A) The normal renal glomerulus of group A (×400). (B) No obvious
pathological change in renal tubules of group A (×400). (C, E) Mild glomerular mesangial proliferation in renal glomerulus of groups B and C
(×400). (D, F) There were no obvious pathological changes in renal tubules in groups B and C (×400).
Wang and Bao European Journal of Medical Research 2013, 18:26 Page 4 of 10
http://www.eurjmedres.com/content/18/1/26
Figure 2 (See legend on next page.)
Wang and Bao European Journal of Medical Research 2013, 18:26 Page 5 of 10
http://www.eurjmedres.com/content/18/1/26
serum ET-1 had a significant positive correlation with
serum MDA (r = 0.8658, P < 0.01), but a negative cor-
relation with serum SOD (r = −0.7793, P < 0.01). NO/
ET-1 ratio had a significant positive correlation with
serum SOD (r = 0.8143, P < 0.01), but a negative cor-
relation with serum MDA (r = −0.9143, P < 0.01).
SOD entered the multiple stepwise regression equa-
tion of NO and ET-1, indicating that oxidative stress
can cause vascular endothelial dysfunction in early
CKD (Table 5).
Our research also found that the experimental group
had a higher level of serum CRP (μg/mL) compared with
groups A and B (group C vs. group A, P < 0.01; group C
vs. group B, P < 0.05) (Table 4), which indicated that the
experimental group had a more obvious micro-inflam-
mation state. Linear regression analysis showed that the
level of serum UA had a significant positive correl-
ation with serum CRP (r = 0.7251, P < 0.05), which in-
dicated that UA was involved in the formation of
micro-inflammation in early CKD. Further, the level
of serum NO had a significant negative correlation
with serum CRP (r = −0.7554, P < 0.05). Serum ET-1
level had a significant positive correlation with serum
CRP (r = 0.7447, P < 0.05). NO/ET-1 ratio had a signifi-
cant negative correlation with serum CRP (r = −0.8042,
P < 0.01). CRP entered the multiple stepwise regression
equation of NO and NO/ET-1 ratio, indicating that mi-
cro-inflammation was involved in the formation of vascu-
lar endothelial dysfunction in early CKD (Table 5).
By studying the levels of serum LDL and ox-LDL, we
found that the experimental group had a higher level of
serum LDL (mmol/L) than groups A and B (group C vs.
group A, P < 0.01; group C vs. group B, P < 0.05) and a
higher level of serum ox-LDL (mmol/L) (group C vs.
group B, P < 0.05) (Table 4). Linear regression analysis
showed that the level of serum UA had a significant posi-
tive correlation with serum ox-LDL (r = 0.8479, P < 0.01)
and serum LDL (r = 0.6356, P < 0.05), which indicated that
UA can cause lipid metabolic disorder in early CKD. Fur-
ther, the level of serum NO had a significant negative cor-
relation with serum ox-LDL (r = −0.7459, P < 0.05), but
no significant correlation with serum LDL (r = −0.5080,
P > 0.05). Serum ET-1 levels had a significant positive
correlation with serum ox-LDL (r = 0.7900, P < 0.01),
but no significant correlation with serum LDL (r = 0.5734,
P > 0.05). NO/ET-1 ratio had a significant negative correl-
ation with serum ox-LDL (r = −0.7949, P < 0.01), but
no significant correlation with serum LDL (r = −0.4947,
P > 0.05). Serum ox-LDL entered the multiple stepwise re-
gression equation of ET-1 (Table 5). The results indicated
that ox-LDL had strong endothelial cell toxicity.
In addition, the percentage of collagen I positive area
in the vascular wall had significant positive correlations
with serum MDA (r = 0.8015, P < 0.01) and serum CRP
(r = 0.6752, P < 0.05), a negative correlation with serum
SOD (r = −0.8180, P < 0.01), and no significant correl-
ation with serum ox-LDL (r = 0.5266, P > 0.05) or serum
LDL (r = 0.5902, P > 0.05) (Table 5). Multiple stepwise
regression analysis showed that serum SOD entered the
equation. According to the results, it was found that oxi-
dative stress and micro-inflammation could lead to an
increase of collagen I deposition in the vessel wall. How-
ever, whether lipid metabolism disorders had a relation
with increased collagen deposition in the vessel wall was
not determined.
In conclusion, UA caused endothelial dysfunction in
early CKD via mechanisms involved in oxidative stress,
micro-inflammation, and abnormal lipid metabolism.
Discussion
In this study, serum UA levels in rats were elevated with
potassium oxonate by gavage. In 1965, it was verified
that potassium oxonate had a strong ability to inhibit
uricase activity both in vivo an in vitro [17]. Many re-
ports have established a hyperuricemia animal model
with potassium oxonate [18]. In this study, we compared
the morphology and biochemical changes of kidney cells
between the experimental group and the control group,
as well as a unilateral nephrectomy group. The experi-
mental group and the unilateral nephrectomy group had
no obvious glomerular lesions; only some of the glom-
erulus presented mild mesangial proliferation. No obvi-
ous abnormality of renal tubules and renal interstitium
was visible. Meanwhile, hyperuricemia kidney disease
caused by urate crystal deposition was not visible in the
experimental group. In serology, serum creatinine levels
among the three groups had no significant difference
(P > 0.05). Nevertheless, the serum UA level of the
experimental group was significantly higher than the
other two groups (about three times). Therefore, we
(See figure on previous page.)
Figure 2 Pathological images of rat arteries from groups A, B, and C. (A) Endothelial cells arranged in order under the vascular intima of
group A (×400). (B) There was no obvious proliferation of medial smooth muscle cells in the vascular wall of group A (×200). (C) The
morphology of endothelial cells of group B was slightly abnormal (×400). (D) There was no obvious proliferation of medial smooth muscle cells
in the vascular wall of group B (×200). (E) Endothelial cells of group C had a foam-like change (×400). (F) Endothelial cells of group C shed from
the vessel wall (×400). (G, H) Inflammatory cells accumulated in the vascular intima of group C (×400). (I) Neutrophil granulocytes were seen
around the endothelial cells of group C (×400). (J) Mononuclear cells were seen around the endothelial cells of group C (×400). (K) Smooth
muscle cells of group C proliferated, thickened, and had no order (×200).
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believe that an early-CKD animal model with hyper-
uricemia was successfully established.
Endothelial dysfunction is prevalent in CKD patients,
and in particular end-stage renal disease patients [19].
Many factors lead to endothelial dysfunction, the mecha-
nisms of which have not been clearly elucidated as yet.
Because of abnormal changes in UA excretion through
the kidney, serum UA levels are higher in CKD patients
compared to the normal population and serum UA con-
tinues to rise with deterioration of renal function. Many
researchers reported that UA was elevated in CKD and
might play a role in the pathophysiology of CKD progres-
sion through endothelial dysfunction, such as activation of
local renin-angiotensin system, increased oxidative stress,
and proinflammatory and proliferative actions [20-22].
This conclusion, although controversial, was supported in
in vitro experimental studies showing the relationship of
UA with NO production and depletion [23,24]. Given that
contention, it was necessary to study the relationship of
UA with early CKD vascular endothelial injury through
animal experiments.
Our experiment showed that the endothelial cells of
the experimental rats presented obvious morphological
changes. In normal circumstances, vascular endothelial
cells inhibit inflammatory cell adhesion and anti-smooth
muscle cell proliferation and migration. However, in ex-
perimental rats, aggregation of inflammatory cells was
observed in the vessel wall, which was even infiltrated
into the intima, accompanied by vascular wall was thick-
ening. Further, smooth muscle cells were hyperplastic,
thickened, irregular, and disorganized. In addition, im-
munohistochemical methods demonstrated that collagen
I increased significantly in the vessel wall. Hence, the
above vasculopathy can be regarded as a consequence of
endothelial injury.
Endothelial cells, an important endocrine organ, can se-
cret many important active substances that play important
roles in the cardiovascular system, such as NO, prostacyc-
lin hormone, endothelin, angiotensin, antithrombin III,
Figure 3 Collagen I staining of the vascular wall in groups A, B, and C. (A,B) A small amount of collagen I deposition was seen in the
vascular wall of group A (×400). (C) Collagen I component was significantly increased in group C (×400).
Table 2 Correlation between serum uric acid and PCIPA,
NO, ET-1, and NO/ET-1 ratio in the vascular wall
Serum uric acid (μmol/L)
r value P value
PCIPA (%) 0.8403 0.0023
NO (μmol/L) −0.9462 0.0000
ET-1 (pg/mL) 0.9374 0.0001
NO/ET-1 ratio −0.9230 0.0001
Table 3 Correlation between PCIPA in the vascular wall
and NO, ET-1, and NO/ET-1 ratio
PCIPA (%)
r value P value
NO (μmol/L) −0.9171 0.0002
ET-1 (pg/mL) 0.8737 0.0010
NO/ET-1 ratio −0.8707 0.0010
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and plasminogen activator. These substances are useful
for homeostasis in the normal case; when the homeostasis
balance is broken, the secretion is abnormal. Therefore, to
a certain extent, endothelial cell function can be assessed
by detecting the concentration of these substances in the
serum. In our study, the substances of contraction and re-
laxation of vascular NO and ET-1 [25], synthesized and
secreted by endothelial cells respectively, were used to as-
sess endothelial cell function. The study found that serum
NO concentration of the experimental group was signifi-
cantly low and ET-1 was significantly high compared to
the unilateral nephrectomy group, indicating that NO and
ET-1 secretion were out of balance. Therefore, we believe
that there is a significant endothelial dysfunction in the
experimental group. Further, line correlation analysis
showed that serum UA level was significantly correlated
with the endothelial function indicators NO and ET-1, in-
dicating that UA has a relation to vascular endothelial cell
dysfunction and participates in early CKD vascular endo-
thelial cell injury.
Increased oxidative stress and reduced antioxidant
capacity are prevalent in CKD patients [26]. Even in pa-
tients with mild renal impairment, oxidative stress level
has increased more significantly than the normal popu-
lation. The level of oxidative stress will intensify as renal
deterioration. Oxidative stress plays an important role in
endothelial cell damage and functional changes [27]. At
present, studies on oxidative stress and endothelial in-
jury mainly focus on end-stage renal disease patients
[28]. The present study focuses on early CKD, and found
that the experimental group has a significant increased
oxidative stress level related to serum UA concentration,
indicating that UA is involved in the formation of the
early CKD oxidative stress status.
Systemic micro-inflammation is widespread in CKD
patients, even accompanied by mild renal dysfunction
[29]. At present, the degree of inflammatory response is
closely related to the incidence and mortality of cardio-
vascular events in CKD patients [30,31]. CRP is an acute
phase protein synthetized by liver in inflammation,
which is recognized as a reliable marker reflecting the
inflammatory state. Our study found that the CRP level
of the experimental group was significantly higher than
the unilateral nephrectomy group, indicating that the
micro-inflammatory state of the experimental group was
more obvious. CRP level was significantly correlated
with serum UA level, showing that UA is involved in the
formation of micro-inflammation in early CKD. Further
analysis showed that serum CRP level was significant
correlated with NO, ET-1, and NO/ET-1 ratio, all of
which are indicators of endothelial function. CRP en-
tered the NO and ET-1 multiple regression equation, in-
dicating that micro-inflammation is involved in vascular
endothelial cell damage of in early CKD.
Table 4 Concentration of serum SOD, MDA, CRP, ox-LDL, and LDL in the three groups (x±̅s)
Group SOD MDA CRP ox-LDL LDL
(U/mL) (nmol/mL) (μg/mL) (mmol/L) (mmol/L)
A 249.80 ± 9.83 4.06 ± 0.28 10.43 ± 1.68 47.50 ± 11.51 0.18 ± 0.06
B 243.60 ± 8.11 4.04 ± 0.41 12.27 ± 2.76 53.31 ± 12.38 0.18 ± 0.06
C 224.40 ± 6.47*# 4.40 ± 0.23△# 14.68 ± 2.01△# 65.22 ± 10.91△# 0.25 ± 0.06△#
Note:
*: P <0.01 group C vs. group B.
△: P <0.05 group C vs. group B.
#: P <0.01 group C vs. group A.
Table 5 Correlation between serum UA, NO, ET-1, and NO/ET-1 ratio as well as PCIPA, SOD, MDA, CRP, ox-LDL, and LDL
Serum uric acid (μmol/L) Serum NO (μmol/L) Serum ET-1 (pg/mL) NO/ET-1 ratio PCIPA (%)
r value P value r value P value r value P value r value P value r value P value
SOD (U/mL) −0.6885 0.0277 0.8179 0.0038 −0.7793 0.0079 0.8143 0.0041 −0.8180 0.0000
MDA (nmol/mL) 0.8195 0.0037 −0.9171 0.0002 0.8658 0.0012 −0.9143 0.0002 0.8015 0.0053
CRP (μg/mL) 0.7251 0.0177 −0.7554 0.0115 0.7447 0.0135 −0.8042 0.0050 0.6752 0.0322
ox-LDL (mmol/L) 0.8479 0.0019 −0.7459 0.0132 0.7900 0.0065 −0.7949 0.0060 0.5266 0.1179
LDL (mmol/L) 0.6356 0.0483 −0.5080 0.1339 0.5734 0.0831 −0.4947 0.1460 0.5902 0.0725
Note: NO as dependent variable and SOD, MDA, CRP, ox-LDL, LDL as independent variables, multiple stepwise regression analysis showed that serum SOD and
CRP entered the equation, and the equation was y = 0.315 × 1-0.802 × 2-22.120 (y = NO, ×1 = SOD, ×2 = CRP; -22.120 was a constant). ET-1 as dependent variable
and SOD, MDA, CRP, ox-LDL, and LDL as independent variables, multiple stepwise regression analysis showed that serum ox-LDL and SOD entered the equation,
and the equation was y = 0.051 × 1-0.082 × 2 + 22.517 (y = ET-1, ×1 = ox-LDL, ×2 = SOD; 22.517 was a constant). NO/ET-1 ratio as dependent variable and SOD, MDA,
CRP, ox-LDL, LDL as independent variables, multiple stepwise regression analysis showed that serum SOD and CRP entered the equation, and the equation was
y = 0.102 × 1-0.316 × 2-13.151 (y = NO/ET-1 ratio, ×1 = SOD, ×2 = CRP; 13.151 was a constant). PCIPA as dependent variable and SOD, MDA, CRP, ox-LDL, LDL as
independent variables, multiple stepwise regression analysis showed that serum SOD entered the equation, and the equation was y = 111.437-0.397 × 1
(y = PCIPA, ×1 = SOD; 111.437 was a constant).
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CKD is often accompanied by lipid metabolic disor-
ders, including increased plasma lipoprotein concentra-
tions and/or lipoprotein composition changes [32]. Our
study found that in the experimental group LDL levels,
as well as its oxidized form ox-LDL, were increased
compared to the unilateral nephrectomy group, both of
which were significantly correlated with UA, suggesting
that UA leads to early CKD lipid metabolic disorders.
Further analysis showed that LDL was not significantly
correlated with endothelial function indicators NO and
ET-1, but its oxidized form was significantly associated
with these indicators. Lipid metabolism disorders might
be involved in endothelial cell damage. It is believable
that only ox-LDL has strong endothelial cell toxicity
compared to LDL. The higher the degree of oxidation,
the stronger the damage is. Our findings also confirmed
this.
Finally, a correlation study about the percentage of
collagen I positive area of the vessel wall and serum UA
levels, endothelial function indicators NO, ET-1, and
NO/ET-1 ratio, as well as the activities of SOD, MDA,
CRP, LDL, and ox-LDL indicated that the percentage of
collagen I positive area of the vessel wall was signifi-
cantly associated with serum UA level, NO, ET-1,
NO/ET-1 ratio, SOD, MDA, and CRP, but had no ob-
vious correlation with LDL and ox-LDL. Based on the
above, we believe that UA causes vascular endothelial
cell injury in early CKD and leads to collagen prolif-
eration in the vessel wall. Meanwhile, collagen hyper-
plasia has a relation to endothelial cell injury. We found
that oxidative stress and micro-inflammation can lead to
increased collagen I deposition in the vessel wall, but
whether lipid metabolism disorders are associated with in-
creased collagen component deposition in the vessel wall
is not yet determined. With the percentage of collagen I
positive area as a dependent variable, multiple stepwise re-
gression analysis showed that serum SOD entered the
equation. Based on these results, we speculate that micro-
inflammation can lead to collagen I proliferation, but
oxidative stress may act in the final passage leading to
increased collagen deposition in the vessel wall.
Conclusions
In summary, this study successfully established an early-
CKD animal model with elevated serum UA by unilateral
nephrectomy plus potassium oxonate intragastrically.
With the animal model, we found UA had a role in early
CKD vascular endothelial cell injury. UA is involved in the
formation of oxidative stress, micro-inflammatory state,
and abnormal lipid metabolism in early CKD, based on
which UA may lead to early CKD vascular endothelial
injury. Therefore, strengthened control the UA level in
early CKD aiming to correct oxidative stress, micro-
inflammatory state, and lipid metabolism disorders, could
improve vascular endothelial function, delay the process
of atherosclerosis, and improve quality of life for CKD
patients.
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